Css LLC Essa Pharma Inc. Put Options Transaction History
Css LLC
- $928 Million
- Q3 2025
Put Options
1 transactions
Others Institutions Holding EPIX
# of Institutions
39Shares Held
20.9MCall Options Held
428KPut Options Held
182K-
Bvf Inc San Francisco, CA11.7MShares$2.33 Million0.12% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT4.36MShares$872,4050.05% of portfolio
-
Morgan Stanley New York, NY1.9MShares$380,8120.0% of portfolio
-
Bank Of America Corp Charlotte, NC592KShares$118,3660.0% of portfolio
-
Lmr Partners LLP London, X0541KShares$108,1960.0% of portfolio
About ESSA Pharma Inc.
- Ticker EPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,073,100
- Market Cap $8.81M
- Description
- ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...